PANP25: Spotlight on IL-13: Long-Term Strategies in the Management of Moderate-to-Severe Atopic Dermatitis: An Online Activity

PANP25: Spotlight on IL-13: Long-Term Strategies in the Management of Moderate-to-Severe Atopic Dermatitis: An Online Activity is organized by Dermsquared .

Release Date: July 17, 2025
Expiration Date: December 22, 2026

Learning Objectives

At the completion of this activity, participants should be better able to:

• Recognize the burden of itch in chronic, recurrent flares in moderate-to-severe atopic dermatitis (AD) despite topical corticosteroid use
• Identify patients with moderate-to-severe AD eligible for biologic therapy according to the 2023 American Academy of Dermatology guidelines
• Examine strategies to optimize the use of IL-13 biologics for the long-term management of moderate-to-severe AD